Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PAVmed (PAVM) Non-Current Assets (2016 - 2025)

PAVmed has reported Non-Current Assets over the past 6 years, most recently at $3.0 million for Q4 2025.

  • For Q4 2025, Non-Current Assets fell 46.52% year-over-year to $3.0 million; the TTM value through Dec 2025 reached $3.0 million, down 46.52%, while the annual FY2025 figure was $3.0 million, 46.52% down from the prior year.
  • Non-Current Assets for Q4 2025 was $3.0 million at PAVmed, down from $3.4 million in the prior quarter.
  • Over five years, Non-Current Assets peaked at $13.3 million in Q1 2022 and troughed at $861000.0 in Q1 2021.
  • A 5-year average of $6.9 million and a median of $6.6 million in 2024 define the central range for Non-Current Assets.
  • Biggest five-year swings in Non-Current Assets: soared 1448.43% in 2022 and later tumbled 47.46% in 2025.
  • Year by year, Non-Current Assets stood at $4.3 million in 2021, then soared by 131.71% to $10.1 million in 2022, then fell by 14.25% to $8.6 million in 2023, then crashed by 35.43% to $5.6 million in 2024, then tumbled by 46.52% to $3.0 million in 2025.
  • Business Quant data shows Non-Current Assets for PAVM at $3.0 million in Q4 2025, $3.4 million in Q3 2025, and $4.8 million in Q2 2025.